Skip to main content

North Carolina Biotechnology Center

ServiceDurham, NC, USAFounded 1984· One of 1986 Service companies tracked by AMPulse

Provides economic development services and funding to accelerate life science technology-based innovation, commercialization, and business growth in North Carolina, including support for additive manufacturing and bioprinting startups.

CEO / Founder
Doug Edgeton, MPH, MBA
Team Size
51-200
Stage
Active
Total Funding
$2.1M
Key Investors
North Carolina General Assembly, Emerging Company Development program

Technology & Products

Key Products

Company Funding programs; Partnership Development Grants; Emerging Company Development program; Strategic Growth Loans; Workforce development initiatives

Technological Advantage

Network advantage through extensive connections with universities, investors, and industry partners in North Carolina's life sciences cluster, facilitating access to resources and funding for AM/bioprinting startups.

Differentiation

Value Proposition

Reduces barriers to entry for life science startups by providing funding, networking, and strategic support, enabling faster commercialization and job creation in sectors like bioprinting and additive manufacturing.

How They Differentiate

Focuses on economic development and support services rather than direct research or product development, with a state-funded model and deep regional integration in North Carolina's life sciences ecosystem.

Market & Competition

Target Customers

Life science companies, startups, universities, and research institutions in North Carolina

Industry Verticals

Biotechnology; Medical Devices; Pharmaceuticals; Agriculture; Additive Manufacturing

Competitors

Baylor Scott & White Research Institute; Foundation Medicine; Trans Genic; Diagenode

Growth & Milestones

Growth Metrics

Supports 830 life sciences companies in North Carolina employing 75,000 workers and generating $88.3 billion in statewide economic activity.

Major Milestones

Founded in 1984 by the North Carolina General Assembly; Invested over $187 million in state funds since inception; Grew from about 5 life sciences companies in 1984 to 830 today

Notable Customers

restor3d; Opus Genetics; Biogen; Novozymes; Fujifilm Diosynth